Clinical Trial Results:
Randomized, double-blind, parallel group, multicenter study to evaluate the
efficacy and safety of four doses of depigmented glutaraldehyde polymerized birch pollen allergenic extract (Depigoid® Birch) in patients with allergic rhinitis and/or rhinoconjunctivitis with or without intermittent asthma
Summary
|
|
EudraCT number |
2008-008448-26 |
Trial protocol |
DE LT |
Global completion date |
21 Feb 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
10 May 2018
|
First version publication date |
10 May 2018
|
Other versions |
|
Summary report(s) |
603-PG-PSC-165_summary 6078-PG-PSC-165_lay man summary |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.